The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Pharmacological interventions for pain in patients with temporomandibular disorders
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2010
|
| DOI | 10.1002/14651858.cd004715.pub2 |
| Pubmed ID | |
| Authors |
Helen R Mujakperuo, Margaret Watson, Roderick Morrison, Tatiana V Macfarlane |
| Abstract |
Temporomandibular disorders (TMD) are a group of disorders affecting the temporomandibular joints and the muscles of mastication. TMDs are treated with a wide range of drugs. The extent to which the use of these drugs is based upon evidence is unknown. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 17% |
| Spain | 2 | 17% |
| Venezuela, Bolivarian Republic of | 1 | 8% |
| Unknown | 7 | 58% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 58% |
| Practitioners (doctors, other healthcare professionals) | 3 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 8% |
| Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 307 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | <1% |
| Germany | 1 | <1% |
| South Africa | 1 | <1% |
| Israel | 1 | <1% |
| Lebanon | 1 | <1% |
| Unknown | 301 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 47 | 15% |
| Student > Bachelor | 35 | 11% |
| Researcher | 33 | 11% |
| Student > Postgraduate | 25 | 8% |
| Student > Doctoral Student | 23 | 7% |
| Other | 65 | 21% |
| Unknown | 79 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 150 | 49% |
| Agricultural and Biological Sciences | 14 | 5% |
| Nursing and Health Professions | 11 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 2% |
| Biochemistry, Genetics and Molecular Biology | 5 | 2% |
| Other | 29 | 9% |
| Unknown | 91 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2022.
All research outputs
#2,088,456
of 26,362,953 outputs
Outputs from Cochrane database of systematic reviews
#4,253
of 13,217 outputs
Outputs of similar age
#7,372
of 111,898 outputs
Outputs of similar age from Cochrane database of systematic reviews
#24
of 84 outputs
Altmetric has tracked 26,362,953 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,217 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,898 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.